January 30, 2018 / 3:48 PM / in 14 minutes BRIEF-Achaogen Announces Upgraded Status For Plazomicin Fill Manufacturer Reuters Staff 1 Min Read 
Jan 30 (Reuters) - Achaogen Inc: 
* SAYS ‍FDA CLASSIFIED OUTCOME OF ITS Q4 2017 REINSPECTION OF PFIZER‘S MCPHERSON FACILITY AS VOLUNTARY ACTION INDICATED​ Source text for Eikon: Further company coverage: